Libra Infusions (DHA:LIBRAINFU) Research & Development: BDT Mil (TTM As of . 20)


DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT642.40
View Full Analysis

What is Libra Infusions Research & Development?

Libra Infusions DHA:LIBRAINFU +0.45% 20 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

Research & Development is the aggregate amount of research and development expenses during the year. Libra Infusions's Research & Development for the six months ended in . 20 was BDT0.00 Mil. Libra Infusions does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Libra Infusions  (DHA:LIBRAINFU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Libra Infusions Research & Development Related Terms

Libra Infusions Research & Development Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Research & Development Chart

Libra Infusions Annual Data
Trend
Research & Development

Libra Infusions Semi-Annual Data
Research & Development
DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' Research & Development too high?
Libra Infusions' current Research & Development is BDT Mil. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Research & Development compare to SECI and LENSF?
Libra Infusions' Research & Development of BDT Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Libra Infusions and its competitors. Libra Infusions's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT642.40
Price